N.C. A&T signs agreement to commercialize hypoallergenic peanut
The patented process, developed by N.C. A&T researchers, reduces allergens in peanuts by 98%, making them safer for people with allergies. The technology can be used to create hypoallergenic peanut butter and other products, and has been demonstrated in human clinical trials.